ABCC12 inhibitors represent a class of chemical compounds designed to modulate the activity of ABCC12, also known as ATP-binding cassette sub-family C member 12. ABCC12 is a member of the ATP-binding cassette (ABC) transporter superfamily, which plays a crucial role in the active transport of various substrates, including ions, lipids, and xenobiotics, across cellular membranes. This subfamily, particularly ABCC12, is primarily associated with drug resistance and the efflux of diverse molecules from cells, contributing to the regulation of intracellular concentrations and maintaining cellular homeostasis.
These inhibitors exert their effects by interfering with the normal functioning of ABCC12. While specific mechanisms may vary among individual inhibitors, the general principle involves blocking key functional sites of the transporter. For example, some inhibitors target the ATP-binding site of ABCC12, preventing the hydrolysis of ATP necessary for the energy-dependent transport of substrates. Others may compete for the substrate-binding site, inhibiting the efflux of specific molecules. Additionally, some inhibitors may alter the conformation of ABCC12 or disrupt its interaction with the cellular membrane, further hindering its transport capabilities. This class of inhibitors plays a pivotal role in research aimed at understanding the fundamental biology of ABCC12 and its implications in cellular processes such as detoxification, maintenance of intracellular homeostasis, and drug resistance. Their study aids in uncovering the intricate mechanisms underlying ABC transporters and may contribute to the development of novel strategies for modulating these transporters in various cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MK-571 | 115103-85-0 | sc-201340 sc-201340A | 5 mg 25 mg | $109.00 $421.00 | 8 | |
MK-571 inhibits ABCC12 by blocking its ATP-binding site. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $29.00 $38.00 | 18 | |
Indomethacin disrupts ABCC12 function by competing for its substrate-binding site. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
Sulfasalazine hinders ABCC12 by disrupting its transport function. | ||||||
Glyburide (Glibenclamide) | 10238-21-8 | sc-200982 sc-200982A sc-200982D sc-200982B sc-200982C | 1 g 5 g 25 g 100 g 500 g | $46.00 $61.00 $117.00 $173.00 $530.00 | 36 | |
Glyburide inhibits ABCC12 by blocking the ATP-binding site. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
Cilostazol interferes with ABCC12 function through its inhibition of ATPase activity. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $53.00 $88.00 | 6 | |
Ibuprofen inhibits ABCC12 by competing for the substrate-binding site. | ||||||
Sulindac | 38194-50-2 | sc-202823 sc-202823A sc-202823B | 1 g 5 g 10 g | $32.00 $86.00 $150.00 | 3 | |
Sulindac disrupts ABCC12 transport activity by blocking its substrate-binding site. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate inhibits ABCC12 by reducing its ATPase activity. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine disrupts ABCC12 function by altering its membrane interactions. | ||||||